Research and Clinical Trials

Title  
Necrotizing Soft Tissue Infections (NSTI)
Brief Description  
Phase III, placebo controlled study to investigate the safety and efficacy of the study drug AB103 in patients with a necrotizing soft tissue infection
Who may be Eligible  
Patients = 12 years of age who have a necrotizing soft tissue infection.
Start Date  
08/05/2015
IRB Number  
08-15-10A
Principal Investigator  
Green, John
Contact Name  
Julia

For More Information, Contact   Julia  Raddatz , MS
Phone:  (704) 355-8287  Fax:  (704) 355-7730 
Email:  julia.raddatz@carolinashealthcare.org
Address:  Carolinas HealthCare System
1000 Blythe Boulevard, MEB-202
Charlotte, NC 28203
Close